+ND Capital

3B Future Health Ventures

4C Biomed Inc.

AAA Family Office

AATec Medical GmbH

AbbVie

AC BioScience SA

Accure Therapeutics S.L.

ActiTrexx GmbH

AdBio Partners

AdimaBio Ventures

adMare BioInnovations

Adoram Therapeutics SA

AFK & Partners Asset Management LLC

Aglaia Oncology Funds

AKIGAI

Akribion Genomics AG

Alder Therapeutics AB

Alentis Therapeutics AG

Aliath Bioventures

Almeda Ventures

Alpina Life Science Advisors

AM-Pharma B.V.

Amarna Therapeutics BV

Amplitude Ventures

AMR Action Fund GP GmbH

Andera Partners

Angelini Ventures S.p.A.

Apollo Health Ventures

Araris Biotech AG

ARTHEx Biotech S.L.

Aslan Pharmaceuticals

AstraZeneca

Atamyo Therapeutics SAS

ATGN Consulting

ATHOS

Aukera Therapeutics

Aurealis Therapeutics AG

Avance Basel GmbH

Azafaros Switzerland AG

BaseLaunch

Bergmann zur Hausen & Cie. GmbH

Berlin Partner für Wirtschaft und Technologie GmbH

BERNINA BioInvest Ltd.

Bio Med Gene Ventures

BioGeneration Ventures

BioLizard SA

BioMedPartners AG

BiomedVC AG

Biopôle SA

Bioqube Ventures

BioReperia AB

biosaxony Management GmbH

BIOSTART Consulting GmbH

BioValley Basel & Suterscience

BioVersys AG

Bioxodes SA

Bird & Bird LLP

BlackRock

Bloomsbury Genetic Therapies

bmp Ventures AG

Boehler Life Science Advice

Boehringer Ingelheim International GmbH

BOHE Angel Fund

Bootstrap Europe

Bpifrance

Bradley Woods & Co. Ltd.

Brainstorm Cell Therapeutics

Brandon Capital

Breakpoint Therapeutics GmbH

Breslin AG

Breslin AG & LSFA

BROTHERS & Partners Europe

Business Angels Switzerland

Cantargia AB

Captor Therapeutics S.A.

CARMA FUND Management GmbH

CasInvent Pharma

Catalyze B.V.

Cathay Health

CEBINA Bridge Capital Ltd.

CENPONTS Europe

CH Consulting Group

Cimeio Therapeutics AG

Circio Holding ASA

Claris Ventures

Cohesion Bureau

Convergence Partners AG

Cooley LLP

Corden Pharma International Switzerland LLC

CoreMedic GmbH

Coulter Partners

CrystalsFirst GmbH

Cukierman & Co. Life Sciences

Cureteq AG

Curie.Bio

Cutanos GmbH

DeBere Capital Partners

Debiopharm International SA

Delin Ventures Ltd.

Dementia Discovery Fund - SV Health Investors LLP

DIAMANTE Healthcare Consulting

Digital Networks PLC

Dimericon Therapeutics AG

docdok.health Ltd.

dRx Capital

Eczacibasi Pharmaceutical and Industrial Investment Co.

Edison Group

eleva GmbH

Eli Lilly and Company

Encelta AG

Epicelya Therapeutics AG

EpimAb Biotherapeutics

EQT Life Sciences

EraCal Therapeutics Ltd.

ESC Advisors

European Investment Bank

Evaxion Biotech A/S

eversyn

EvlaBio AG

Evoleen AG

Expert Systems

F. Hoffmann-La Roche AG

Ferghana Partners

Finanz und Wirtschaft / Tamedia

Flerie Invest AB

FluoSphera

Forbion

Forty51 Ventures AG

FoRx Therapeutics AG

Fraser Finance

Fraunhofer IZI (Institute for Cell Therapy and Immunology)

FreeMind Group

Fusix Biotech

FutuRx

GALSER SA

Generation Fund Life Sciences Fund I

Genesis Theranostix Group

Genius Search GmbH & Co. KG

GIBF

Gilde Healthcare

Gimv

Glycostem Therapeutics B.V.

Goethe CVI GmbH

GOLDTRACK Ventures GmbH

GQ Bio Therapeutics GmbH

H Tree Capital

Hadean Ventures

HBM Partners AG

Health Innovation Capital

Heidelberg Pharma AG

Heidi.news

Helmholtz Munich

Hêmera srl

High-Tech Gründerfonds

Hong Kong Exchanges and Clearing Limited

Hong Kong Trade Development Council

Humanetics Corporation

IAG Italian Angels for Growth

ICF Consult Switzerland

Indaco Bio Fund

Indaco Venture Partners SGR S.p.A.

Innovent Biologics

Innovestor Life Science Ltd.

Intermediate Capital Group PLC

Intravacc B.V.

Inversago Pharma Inc.

Invest in Skåne

InvestHK

iOmx Therapeutics AG

IPF Partners

Ipsen

J.P. Morgan Asset Management

Jeito Capital

Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation LLC

JPMorgan Chase & Co.

Kamari Pharma Ltd.

KBI Biopharma

KBio

Kerna Ventures

Kinled Holding Limited

KIZOO Technology Capital GmbH

Kurma Partners

L.E.K. Consulting

Landmark BioVentures AG

Landmark Family Office/Landmark Angels

Leads To Development

Legacy Healthcare

LIfT BioSciences Ltd.

LMU Munich

Lonza AG

LSA Ventures

LSV Capital Partners

Lynx Financial Hong Kong Ltd.

M Ventures

M&G Advisors GmbH

M2Care

Mabylon AG

Macomics Ltd.

MC Services AG

MC2 Therapeutics A/S

MCE Carrel Avocats SA

Medeor Associates

Medicxi

MEDiSTRAVA

MedNous

Meru Advisors LLC

Mestag Therapeutics Ltd.

MetrioPharm AG

MicroCures

Mid Atlantic Bio Angels

Momentum Biotech LLC

MRM Health

MSD

MV BioTherapeutics SA

Nanoligent SL

NatIgGs GmbH

Neuropause Medical

New Science Fund

NewAmsterdam Pharma

Novartis AG

Novartis Venture Fund

Novavax CH GmbH

Novo Holdings A/S

NRW.Venture

NXI Therapeutics AG

NxR Biotechnologies GmbH

Oberland Capital

ObserVa Capital

Ochre Bio

Octopus Ventures

Omega Funds

Oryzon Genomics

Oxford BioTherapeutics Ltd.

Oxford Science Enterprises

Panakès Partners SGR SpA

Paul Larue Business Development Consulting

PDC*line Pharma SA

Perseo Pharma AG

Pfizer

Phialogics AG

Pictet & Cie SA

Pilatus Biosciences SA

Pioneer Fund

Prevail Partners LLC

Private Equity Investor

Prolevi Bio AB

PROSION Therapeutics

ProteKt Therapeutics Ltd.

Pureos Bioventures

Quadrille Capital

Redalpine Venture Partners AG

Rejuveron Life Sciences AG

Rinri Therapeutics Ltd.

River BioMedics

RNATICS GmbH

Roche Venture Fund

Roivant Sciences GmbH

Rosetta Capital Ltd.

Roy Consulting

RV Invest

Salvina Therapeutics AG

Sanofi

Sapient Therapeutics Ltd.

Schroders Capital

Scius Communications

SDS Optic Inc.

Secarna Pharmaceuticals GmbH & Co. KG

Second Thought

Seroba Life Sciences

SixPeaks Bio

Sound Bioventures Management AB

SPRIM Global Investments

Staatz Business Development & Strategy

STALICLA SA

StemInov SAS

Stephens Research

Stifel

STIMUNITY SAS

Strategic Transactions Advisory AG

Sunstone Life Science Ventures

Superlab Suisse AG

Swiss Biotech Association

Symeres B.V.

Syncona Investment Management Ltd.

Tagworks Pharmaceuticals BV

Taiho Ventures

TargImmune Therapeutics AG

TauC3 Biologics Limited

TBD Pharmatech OÜ

TheraVenture GmbH

Thermosome GmbH

Tillotts Pharma AG

TILT Biotherapeutics

TME Pharma

TOLREMO Therapeutics AG

Tridek-One

TruVenturo GmbH

Turenne Capital

Turos Capital AG

TVM Capital Life Science

UCB Pharma

University Hospital of Zürich

University of Zurich

Urania Therapeutics

Vaccentis AG

VALANX Biotech GmbH

Valor Management

Vandria SA

Venture Valuation AG

Versant Ventures

Vesalius Biocapital IV

VI Partners AG

Vidac Pharma Holding PLC

VirdisGroup Limited

Vogel BioC

VU Venture Partners

WG Partners

X-Chem

XENOTHERA SAS

XGEN Venture SGR S.p.A.

XNK Therapeutics AB

XOventure GmbH

Ymmunobio AG

Ysios Capital Partners S.G.E.I.C.